Table: Shin Nippon Biomedical -Q1 group results

Shin Nippon Biomedical Laboratories

02/08/2023 04:00

Aug 2 (Reuters)- 
             Shin Nippon Biomedical Laboratories Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2023        Jun 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             5.80                4.05             30.37    
                 (+43.5 pct)         (+33.1 pct)      (+21.0 pct) 
  Operating         1.23               714 mln            5.02    
                 (+71.9 pct)         (+45.2 pct)      (-4.3 pct)  
  Recurring         1.88                2.77              7.18    
                 (-32.3 pct)        (+312.1 pct)      (-21.9 pct) 
  Net               1.37                1.94              4.78    
                 (-29.4 pct)         (+6.5 pct)       (-21.1 pct) 
  EPS             32.98 yen           46.70 yen       114.81 yen  
  Ann Div                             50.00 yen        50.00 yen  
  -Q2 div                             20.00 yen        20.00 yen  
  -Q4 div                             30.00 yen        30.00 yen  
  
  NOTE - Shin Nippon Biomedical Laboratories Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T